Principal Investigator
Richard Preston
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210444
Clinical Trial Summary
A PHASE I, MULTICENTER, OPEN-LABEL, PARALLEL-GROUP, PHARMACOKINETIC SINGLE DOSE STUDY OF GANAXOLONE IN ADULT SUBJECTS WITH NORMAL AND IMPAIRED HEPATIC FUNCTION
Phase
Phase I
Funding Agency/Sponsor
Industry
Disease
Other